This protocol is judged by an institutional assessment board, an impartial team that assessments any scientific trials involving human beings. If a analyze will involve a Routine I drug, once the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) variety with the FDA.copyright i